Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,322 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07444112Recruiting
Myofascial release for text neck in university students
This trial tests if a hands-on therapy called myofascial release can help university students with text neck (neck pain from looking down at phones). It aims to reduce pain and improve neck function.
Lahore, Punjab ProvinceAges 18–30 - NCT07436793RecruitingPhase 2
Progestin therapy before hysterectomy for endometrial cancer
This trial tests whether taking progestin (a hormone medication) before scheduled surgery can improve outcomes for women with a type of uterine cancer called endometrioid adenocarcinoma. You might be able to join if you are planning to have a hysterectomy and are open to hormone therapy before the procedure.
Iowa City, IowaAges 18 years+ - NCT07435974Recruiting
Online treatment for binge eating in Chile
This trial tests an online program to help adults in Chile who have frequent binge eating and are overweight. It aims to reduce binge eating and improve health without changing your current medications if they are stable.
Temuco, La AraucaníaAges 18 years+ - NCT07444242Recruiting
Fast depression treatment using brain stimulation
This trial tests whether a non-invasive brain stimulation technique called tDCS can quickly improve depression symptoms. It is for people who are not taking any psychiatric medications now or in the past.
Regensburg, BavariaAges 18–70 - NCT07440277Recruiting
Shunt vs. stent for IIH with vision loss risk
This study compares two treatments for Idiopathic Intracranial Hypertension (IIH) with severe papilledema (swollen optic nerves) and risk of vision loss: a CSF shunt (a tube to drain extra fluid) and a venous sinus stent (a mesh tube to open a narrowed vein). The goal is to see which works better and is more cost-effective.
BirminghamAges 18–63 - NCT07437768Enrolling by invitation
Vonoprazan test for acid reflux that doesn't respond to standard medicine
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
New Taipei City, TaiwanAges 20–75 - NCT07438002Recruiting
Exercise for kidney disease patients on dialysis or in treatment
This trial studies whether high-intensity physical exercise helps people with chronic kidney disease, including those on dialysis. It aims to improve health and physical function.
Peschiera del Garda, VeronaAges 18 years+ - NCT07438847RecruitingPhase 1
New radioactive treatment for advanced thyroid cancer
This trial tests a new radioactive treatment (177Lu-CTR-FAPI) that targets a protein on thyroid cancer cells. It's for people whose thyroid cancer has stopped responding to standard treatments, including radioactive iodine and targeted therapies.
BeijingAges 18 years+ - NCT07440290RecruitingPhase 2/Phase 3
Dabrafenib and trametinib for BRAF V600 cancers
This trial tests two targeted drugs (dabrafenib and trametinib) for patients whose cancer has a specific change in the BRAF gene called V600. These drugs work together to block signals that help the cancer grow. The trial is for children, teenagers, and adults with many types of cancer, except for a few common ones that already have approved treatments.
BelfastAges 1 year+ - NCT06072105Recruiting
Medical decisions in multiple system atrophy: a study in Austria
This study looks at how medical decisions are made for people with multiple system atrophy (MSA). It includes both people with MSA and their unpaid caregivers who live in Austria and speak German. Participants and caregivers will share their experiences through online interviews to help improve future care.
Innsbruck, AustriaAges 30 years+ - NCT06424964Recruiting
HIV treatment study for injectable cabotegravir/rilpivirine in Belgium
This study looks at people in Belgium who have already received at least one dose of a long-acting injectable HIV medication called cabotegravir/rilpivirine. The goal is to learn more about how this treatment works in real-world settings.
BrusselsAges 18–99 - NCT06808373Recruiting
Hypnosis for gum disease treatment
This study tests whether hypnosis can help with gum disease treatment. It is for adults who have chronic gum disease but are otherwise healthy.
AfyonkarahisarAges 20–65 - NCT06808724Recruiting
Effect of implant surface treatment on stability
This trial compares how different surface treatments on dental implants affect their stability. It is for people who need implants in both upper premolar/molar areas and have healed enough bone without grafts.
Trieste, TSAges 18 years+ - NCT06809231Recruiting
Long-term follow-up of CartiONE for knee cartilage repair
This study follows people who had CartiONE treatment for a knee cartilage lesion more than 6 months ago. Researchers want to see how well the treatment works and how safe it is over 1 to 13 years.
Ghent, Oost-VlaanderenAges 18 years+ - NCT04567030Recruiting
AI tool to help improve gum treatment outcomes
This trial tests whether an artificial intelligence (AI) system can help plan and improve results of gum (periodontal) treatment. You may be a good match if you have diagnosed periodontal disease and enough healthy teeth.
Kaohsiung CityAges 35–65 - NCT06028672Recruiting
Immunotherapy plus chemotherapy for moderate-risk GTN
This trial tests a combination of an immunotherapy drug (toripalimab) and a chemotherapy drug (actinomycin-D) as the first treatment for gestational trophoblastic neoplasia (GTN) with a FIGO score of 5-6. It may help patients whose disease is at a moderate risk level.
Beijing, Beijing MunicipalityAges 18–60 - NCT05726721Recruiting
Study of treatment targets for binge eating disorder
This trial studies how binge eating disorder behaves during treatment and compares patterns over time. It may help by improving future treatment approaches for people with binge eating disorder.
Aarhus, Central JutlandAges 18 years+ - NCT06083649Recruiting
Dental education: AI vs. human counseling for gum disease
This trial compares two ways of teaching about dental care—AI-assisted education versus speaking with a counselor—to see which one helps people with gum disease better control plaque and improve treatment outcomes.
Kaohsiung CityAges 35–65 - NCT06222723RecruitingPhase 2
Testing dexamethasone as an additional treatment for Lassa fever
This trial tests whether adding dexamethasone, a steroid that reduces inflammation, to standard care can help people with severe Lassa fever. It is for adults who are very sick with confirmed Lassa fever.
Irrua, EdoAges 18 years+ - NCT06715085RecruitingPhase 4
PRGF injections for chronic low back pain
This trial tests whether injections of a blood-based treatment called PRGF can help people with long-term low back pain caused by worn discs. It is for those who haven't gotten relief from standard treatments like medication.
Vitoria-Gasteiz, AlavaAges 18 years+ - NCT06718946RecruitingEarly Phase 1
IV IDOV-SAFE for advanced solid tumors: safety and effect study
This trial tests a new drug called IDOV-SAFE given through a vein. It is for people with advanced solid tumors that have not responded to standard treatments. The study aims to see if the drug is safe and if it can help shrink tumors.
ShanghaiAges 18–75 - NCT07426224Enrolling by invitation
Blood sugar screening for advanced gum disease patients
This trial checks if treating advanced gum disease at a specialist clinic can help find hidden high blood sugar and support you in managing your overall health.
StockholmAges 18 years+ - NCT07433075Recruiting
Testing a planning software for brain aneurysm treatment
This study tests Sim&Size, a software that helps doctors plan how to place implants to treat unruptured brain aneurysms. The trial looks at whether using this software improves outcomes and reduces costs.
AngersAges 18 years+ - NCT07430306RecruitingPhase 3
Study of anifrolumab for lupus patients not yet on strong treatments
This trial tests if a new drug called anifrolumab can help treat lupus in people who haven't taken strong medications like biologics or immunosuppressants before. It looks at overall disease activity and the chance to reduce steroid use.
Anniston, AlabamaAges 18–70
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,322 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.